Robert F. Kennedy Jr. has disclosed undergoing an unproven stem cell treatment at a clinic in Antigua, sparking discussions about the broader implications of such procedures and regulatory oversight.

Kennedy made the admission during a public appearance at a regenerative medicine roundtable, where he shared details of his experience with the experimental therapy.

The treatment reportedly took place at an offshore clinic, which operates outside U.S. Food and Drug Administration (FDA) jurisdiction. Stem cell therapies have long been a subject of debate due to their potential benefits and risks, particularly when administered without robust clinical evidence or regulatory approval.

Kennedy’s acknowledgment comes amid growing concerns about the possibility of increased deregulation in the field of regenerative medicine under current administrative policies.

Experts have raised questions about patient safety and ethical standards as more individuals seek treatments from clinics operating in countries with less stringent oversight.